Causal Inference for Continuous Multiple Time Point Interventions (2305.06645v6)
Abstract: There are limited options to estimate the treatment effects of variables which are continuous and measured at multiple time points, particularly if the true dose-response curve should be estimated as closely as possible. However, these situations may be of relevance: in pharmacology, one may be interested in how outcomes of people living with -- and treated for -- HIV, such as viral failure, would vary for time-varying interventions such as different drug concentration trajectories. A challenge for doing causal inference with continuous interventions is that the positivity assumption is typically violated. To address positivity violations, we develop projection functions, which reweigh and redefine the estimand of interest based on functions of the conditional support for the respective interventions. With these functions, we obtain the desired dose-response curve in areas of enough support, and otherwise a meaningful estimand that does not require the positivity assumption. We develop $g$-computation type plug-in estimators for this case. Those are contrasted with g-computation estimators which are applied to continuous interventions without specifically addressing positivity violations, which we propose to be presented with diagnostics. The ideas are illustrated with longitudinal data from HIV positive children treated with an efavirenz-based regimen as part of the CHAPAS-3 trial, which enrolled children $<13$ years in Zambia/Uganda. Simulations show in which situations a standard g-computation approach is appropriate, and in which it leads to bias and how the proposed weighted estimation approach then recovers the alternative estimand of interest.
- Marginal structural models and causal inference in epidemiology. Epidemiology, 11(5):550–560, 2000.
- J. Robins. A new approach to causal inference in mortality studies with a sustained exposure period - application to control of the healthy worker survivor effect. Mathematical Modelling, 7(9-12):1393–1512, 1986.
- H. Bang and J. M. Robins. Doubly robust estimation in missing data and causal inference models. Biometrics, 64(2):962–972, 2005.
- M. Van der Laan and S. Rose. Targeted Learning. Springer, 2011.
- Effect of breastfeeding on gastrointestinal infection in infants: A targeted maximum likelihood approach for clustered longitudinal data. Annals of Applied Statistics, 8(2):703–725, 2014.
- Using longitudinal targeted maximum likelihood estimation in complex settings with dynamic interventions. Statistics in Medicine, 38:4888–4911, 2019.
- Estimating the effect of central bank independence on inflation using longitudinal targeted maximum likelihood estimation. Journal of Causal Inference, 9(1):109–146, 2021.
- The impact of delayed switch to second-line antiretroviral therapy on mortality, depending on failure time definition and CD4 count at failure. American Journal of Epidemiology, 189:811–819, 2020.
- Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. International Journal of Epidemiology, 45(6):2038–2049, 2016.
- Estimating the Comparative Effectiveness of Feeding Interventions in the Pediatric Intensive Care Unit: A Demonstration of Longitudinal Targeted Maximum Likelihood Estimation. American Journal of Epidemiology, 186(12):1370–1379, 2017.
- The Propensity Score with Continuous Treatments, chapter 7, pages 73–84. Wiley, 2004.
- Evaluation of the effect of a continuous treatment: A machine learning approach with an application to treatment for traumatic brain injury. Health Economics, 24(9):1213–1228, 2015.
- Nonparametric methods for doubly robust estimation of continuous treatment effects. Journal of the Royal Statistical Society. Series B, Statistical methodology, 79:1229–1245, 2017.
- Causal isotonic regression. Journal of the Royal Statistical Society, Series B, 82:719–747, 2020.
- Causal inference with a quantitative exposure. Statistical Methods in Medical Research, 25(1):315–335, 2016.
- Uniformly semiparametric efficient estimation of treatment effects with a continuous treatment. Journal of the American Statistical Association, 110(512):1528–1542, 2015.
- Inference for causal interactions for continuous exposures under dichotomization. Biometrics, 67(4):1414–1421, 2011.
- Iván Díaz and Mark J. van der Laan. Targeted data adaptive estimation of the causal dose–response curve. Journal of Causal Inference, 1(2):171–192, 2013.
- R. Neugebauer and M. van der Laan. Nonparametric causal effects based on marginal structural models. Journal of Statistical Planning and Inference, 137(2):419–434, 2007.
- Estimation of controlled direct effects. Journal of the Royal Statistical Society Series B-Statistical Methodology, 70:1049–1066, 2008.
- Identification, estimation and approximation of risk under interventions that depend on the natural value of treatment using observational data. Epidemiologic Methods, 3(1):1–19, 2014.
- Inverse probability weighted estimation of risk under representative interventions in observational studies. Journal of the American Statistical Association, 114(526):938–947, 2019.
- Non-parametric causal effects based on longitudinal modified treatment policies. Journal of the American Statistical Association, in press, 2021.
- Abacavir, zidovudine, or stavudine as paediatric tablets for african hiv-infected children (chapas-3): an open-label, parallel-group, randomised controlled trial. The Lancet Infectious Diseases, 16(2):169–79, 2016.
- Plasma efavirenz exposure, sex, and age predict virological response in hiv-infected african children. Journal of Acquired Immune Deficiency Syndromes, 73(2):161–168, 2016a.
- Determinants of virological outcome and adverse events in african children treated with paediatric nevirapine fixed-dose-combination tablets. AIDS, 31(7):905–915, 2017.
- Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimen. Antiviral Therapy, 19(4), 2014.
- Effect of lopinavir and nevirapine concentrations on viral outcomes in protease inhibitor-experienced HIV-infected children. Pediatric Infectious Disease Journal, 35(12):e378–e383, 2016.
- Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy. International Journal of Antimicrobial Agents, 47(6):466–472, 2016.
- M. Hernan and J. Robins. Causal inference. Chapman & Hall/CRC, Boca Raton, 2020. URL https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/.
- Targeted maximum likelihood estimation for dynamic and static longitudinal marginal structural working models. Journal of Causal Inference, 2(2):147–185, 2014.
- Targeted minimum loss based estimation of causal effects of multiple time point interventions. International Journal of Biostatistics, 8(1):article 9, 2012.
- M. L. Petersen. Commentary: Applying a causal road map in settings with time-dependent confounding. Epidemiology, 25(6):898–901, 2014.
- A causal framework for classical statistical estimands in failure-time settings with competing events. Statistics in Medicine, 39(8):1199–1236, 2020.
- Iván Díaz and Mark van der Laan. Super learner based conditional density estimation with application to marginal structural models. The International Journal of Biostatistics, 7(1):Article 38, 2011. URL https://doi.org/10.2202/1557-4679.1356.
- Diagnosing and responding to violations in the positivity assumption. Statistical Methods in Medical Research, 21(1):31–54, 2012.
- Introduction to Statistics and Data Analysis - With Exercises, Solutions and Applications in R. Springer, Heidelberg, 2023.
- haldensify: Highly adaptive lasso conditional density estimation, 2022a. URL https://github.com/nhejazi/haldensify. R package version 0.2.3.
- ‘haldensify‘: Highly adaptive lasso conditional density estimation in ‘r‘. Journal of Open Source Software, 7(77):4522, 2022b. doi: 10.21105/joss.04522. URL https://doi.org/10.21105/joss.04522.
- The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in african children. British Journal of Clinical Pharmacology, 82(1):185–98, 2016b.
Paper Prompts
Sign up for free to create and run prompts on this paper using GPT-5.
Top Community Prompts
Collections
Sign up for free to add this paper to one or more collections.